40.50GBP0.00%Mkt Cap: 105.39M $P/E: —1d ago
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company's lead product candidate is Bexmarilimab, a novel anti-Clever-1 humanized antibody that targets a subpopulation of…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap105.39M $
Enterprise Value75.29M $
Revenue (TTM)1.68M $
Gross Profit1.68M $
Net Income (TTM)-34.96M $
Revenue/Share0.0154 USD
Last Price40.50 GBP
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees33
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.29
PEG—
EV/EBITDA-2.93
EV/Revenue44.88
P/S62.82
P/B-2.93
EPS (TTM)-0.19
EPS (Forward)-0.09
52W Range
38.7055% of range42.00
52W High42.00 GBP
52W Low38.70 GBP
Profitability
Gross Margin100.00%
Oper. Margin-638.99%
EBITDA Margin0.00%
Profit Margin0.00%
ROE147.28%
ROA-158.73%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-22.98M $
CapEx (TTM)284.74K $
FCF Margin-866.94%
FCF Yield-13.80%
Net Debt15.86M $
Net Debt/EBITDA-0.62
Balance Sheet
Debt/Equity-1.33
Current Ratio0.84
Quick Ratio0.68
Book Value/Sh-0.1384 GBP
Cash/Share0.1080 GBP
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBP
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1002.22 GBP
Upside (mean)+2374.6%
Target Range1002.22 GBP – 1002.22 GBP
# Analysts1
Ownership
Shares Out.202.88M
Float90.41M
Insiders16.44%
Institutions22.27%
Technical
SMA 5041.69 (-2.9%)
SMA 20086.77 (-53.3%)
Beta1.12
S&P 52W Chg18.16%
Avg Vol (30d)23.95K
Avg Vol (10d)54.96K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—